MEGAN RUNGE: Open Payments
NPI 1508385832 · PITTSBURG, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 15 payments from 7 companies in 2025. Trend: 2023 $190 · 2024 $232 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $353 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| Organogenesis Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $21 |
| PFIZER INC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: BREZTRI, REXULTI, UBRELVY, FARXIGA, SIMPLIMAX, Fluad, AIRSUPRA, NURTEC ODT.
Industry payments across KS — which companies pay providers there.
